HealthQuill Pharma
GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.
Drugs Medical Pharma

GSK offloads 300 million shares in Haleon for $1.2 billion

HQ Team January 19, 2024: GSK is giving up more of its stake in Haleon, the consumer health business the British pharma giant.

Read More
The FDA has approved US-based DermaSensor Inc.'s handheld wireless skin cancer detection device that is powered by artificial intelligence technology.
Drugs Medical Pharma

FDA green lights DermaSensor’s skin cancer detection device in the US

HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.

Read More
The number of adults who smoke has fallen to one in five from one in three in 2000 with 150 nations reducing tobacco use successfully, according to the World Health Organization.
Health Medical Pharma

More smokers quit globally, WHO warns against industry’s tactics

HQ Team January 16, 2024: The number of adults who smoke has fallen to one in five from one in three in 2000.

Read More
The government of South Georgia and the South Sandwich Islands has detected avian influenza in mammals for the first time in the sub-Antarctica region, threatening its fragile ecosystem and the risk of the disease spreading to other seabirds and sea mammals.
Climate Health Pharma

First confirmed case of avian influenza in mammals found in sub-Antarctica 

HQ Team January 16, 2024: The government of South Georgia and the South Sandwich Islands has detected avian influenza in mammals for the.

Read More
There are five species of plasmodium of which plasmodium falciparum is the deadliest and poses the greatest threat in Africa.
Drugs Health Pharma

Opinion: Vaccine for malaria took a while, but it’s worth the wait

By K. Leelamoni January 16, 2024: Vaccination is a simple, safe and effective method of protecting the body against infectious diseases. Ever since.

Read More
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.
Drugs Medical Pharma

Merck’s Keytruda receives FDA nod for cervical cancer treatment

HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.

Read More
Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with diabetic peripheral neuropathy has yielded positive results.
Drugs Medical Pharma

Venture capitalists, scientists plan biomedical research unit for new drugs

HQ Team January 13, 2024: High-profile scientists and financiers are pooling resources to launch a biomedical research facility that they claim will offer.

Read More
The first human trials for a vaccine against Nipah virus have been started by the University of Oxford, according to a statement.
Drugs Health Pharma

University of Oxford starts human trials to develop vaccine against Nipah virus 

HQ Team January 11, 2023: The first human trials for a vaccine against Nipah virus have been started by the University of Oxford,.

Read More
British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes medicines to treat asthma.
Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion  

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Pharma

Novo Nordisk diabetes drug meets trial goals against insulin glargine

 HQ Team January 9, 2023: Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in.

Read More